Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.66% |
| 2 | Consumer Discretionary | 8.08% |
| 3 | Energy | 7.71% |
| 4 | Technology | 6.85% |
| 5 | Industrials | 5.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
PUT
Constellation Brands
STZ
$23.8B
| $1.26M | ﹤0.01% |
21,900
-33,500
| -60% | -$1.82M |
|
2752
PUT
Angi Inc
ANGI
$191M
| $1.26M | ﹤0.01% |
5,580
+2,410
| +76% | +$561K |
|
2753
CALL
Annaly Capital Management
NLY
$17.6B
| $1.25M | ﹤0.01% |
27,100
+15,475
| +133% | +$728K |
|
2754
PUT
M&T Bank
MTB
$36.7B
| $1.25M | ﹤0.01% |
11,200
-3,500
| -24% | -$405K |
|
2755
Trustmark
TRMK
$2.8B
| $1.25M | ﹤0.01% |
48,911
-2,132
| -4% | -$55.8K |
|
2756
Alaska Air
ALK
$5.13B
| $1.25M | ﹤0.01% |
39,872
-74,392
| -65% | -$2.22M |
|
2757
PUT
FTI Consulting
FCN
$4.19B
| $1.25M | ﹤0.01% |
33,000
-13,800
| -29% | -$489K |
|
|
EVEP
2758
CALL
DELISTED
EV Energy Partners, L.P.
EVEP
| $1.25M | ﹤0.01% |
33,600
-7,200
| -18% | -$275K |
|
2759
Sanofi
SNY
$105B
| $1.25M | ﹤0.01% |
24,594
-10,483
| -30% | -$533K |
|
|
MON
2760
DELISTED
Monsanto Co
MON
| $1.24M | ﹤0.01% |
11,905
-62,708
| -84% | -$6.3M |
|
2761
CALL
Eagle Materials
EXP
$6.4B
| $1.24M | ﹤0.01% |
17,100
-22,600
| -57% | -$1.54M |
|
2762
PUT
Targa Resources
TRGP
$59.1B
| $1.24M | ﹤0.01% |
+17,000
| New | +$1.17M |
|
|
ATMI
2763
DELISTED
A T M I INC
ATMI
| $1.24M | ﹤0.01% |
46,743
-55,400
| -54% | -$1.41M |
|
2764
PUT
United Therapeutics
UTHR
$21.4B
| $1.24M | ﹤0.01% |
15,700
-5,700
| -27% | -$417K |
|
2765
PUT
Smith & Wesson
SWBI
$643M
| $1.24M | ﹤0.01% |
146,493
+10,278
| +8% | +$88.9K |
|
|
WNR
2766
CALL
DELISTED
Western Refining Inc
WNR
| $1.24M | ﹤0.01% |
41,100
-21,600
| -34% | -$635K |
|
|
SA
2767
CALL
Seabridge Gold
SA
$3.62B
| $1.23M | ﹤0.01% |
117,900
+24,000
| +26% | +$296K |
|
|
WPZ
2768
PUT
DELISTED
WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT
WPZ
| $1.23M | ﹤0.01% |
24,733
-13,057
| -35% | -$625K |
|
2769
PUT
Cardinal Health
CAH
$54.7B
| $1.23M | ﹤0.01% |
23,600
-18,400
| -44% | -$935K |
|
2770
PUT
Canadian Solar
CSIQ
$1.03B
| $1.23M | ﹤0.01% |
72,400
+19,900
| +38% | +$266K |
|
2771
Lincoln Electric
LECO
$15.6B
| $1.23M | ﹤0.01% |
+18,431
| New | +$1.16M |
|
2772
PUT
First Majestic Silver
AG
$9.49B
| $1.22M | ﹤0.01% |
103,000
+35,800
| +53% | +$468K |
|
2773
PUT
Cheesecake Factory
CAKE
$5.64B
| $1.22M | ﹤0.01% |
27,800
+5,200
| +23% | +$224K |
|
2774
Park National Corp
PRK
$3.75B
| $1.22M | ﹤0.01% |
15,390
+4,666
| +44% | +$365K |
|
|
IMMU
2775
DELISTED
Immunomedics Inc
IMMU
| $1.22M | ﹤0.01% |
196,566
+20,907
| +12% | +$120K |
|
Similar funds
Ken Griffin's Q3 2013 Portfolio in Review
As of Q3 2013, Ken Griffin held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Ken Griffin's Q3 2013 filing shows 735 new, 2,740 increased, 3,074 reduced and 505 closed positions. Its largest new stake was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M. The largest sale was Pfizer, an estimated $245M.
By sector, the portfolio is most concentrated in Financials at 9.7% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Energy.
- Ken Griffin's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Ken Griffin added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Ken Griffin's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Ken Griffin fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Ken Griffin's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Ken Griffin opened 735 new positions and closed 505 in Q3 2013.
- Ken Griffin's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.